Abstract | BACKGROUND: OBJECTIVE: To compare the efficacy and tolerability of adapalene gel 0.1% and isotretinoin gel 0.05% in the treatment of acne vulgaris of the face, in a randomized open-label clinical trial. METHODS: Eighty patients were enrolled and were instructed to apply adapalene gel 0.1% or isotretinoin gel 0.05% once daily over a 12-week treatment period. Efficacy determination included noninflammatory and inflammatory lesion counts by the investigator and global evaluation of improvement. Cutaneous tolerance was assessed by determining erythema, scaling and burning with pruritus. RESULTS:
Adapalene and isotretinoin gels were highly effective in treating facial acne. Adapalene gel produced greater reductions in noninflammatory and inflammatory lesion counts than did isotretinoin gel, but differences between treatments were not statistically significant. Adapalene gel was significantly better tolerated than isotretinoin gel during the whole treatment period. CONCLUSIONS:
|
Authors | D Ioannides, D Rigopoulos, A Katsambas |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 147
Issue 3
Pg. 523-7
(Sep 2002)
ISSN: 0007-0963 [Print] England |
PMID | 12207595
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Dermatologic Agents
- Gels
- Keratolytic Agents
- Naphthalenes
- Adapalene
- Isotretinoin
|
Topics |
- Acne Vulgaris
(drug therapy, pathology)
- Adapalene
- Administration, Topical
- Adolescent
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, therapeutic use)
- Dermatologic Agents
(adverse effects, therapeutic use)
- Female
- Gels
- Humans
- Isotretinoin
(adverse effects, therapeutic use)
- Keratolytic Agents
(adverse effects, therapeutic use)
- Male
- Naphthalenes
(adverse effects, therapeutic use)
- Treatment Outcome
|